Zepp Health, the parent company of Amazfit, has announced the acquisition of the core assets and intellectual property of Wild.AI, a platform specializing in hormone-informed wellness for women. The acquisition, finalized at the end of August, includes Wild.AI’s proprietary technology and select leadership team members.
Advancing Women’s Health Through AI-Driven Insights
Wild.AI is renowned for its use of physiological and hormonal data to help women track, train, fuel, and recover based on their cycle and life stage. From menstruation to menopause, the platform delivers personalized insights that aim to improve performance, reduce injury risk, and enhance body awareness. This acquisition builds upon a successful partnership between Zepp Health and Wild.AI, highlighted by the recent launch of a Wild.AI mini-app on Amazfit’s Active 2 smartwatch.
Also Read: Predoc secures $30M to end document chasing in healthcare
Integration with Wearable Technology
As part of the acquisition, Zepp Health plans to integrate Wild.AI’s capabilities into its wearable technology ecosystem. This integration aims to provide users with enhanced health insights and personalized wellness recommendations directly through their devices. The global rollout of Wild.AI features across Amazfit devices is set to begin in the United States.
Commitment to Women’s Health
Zepp Health’s acquisition of Wild.AI underscores its commitment to addressing the unique health needs of women. By incorporating hormone-informed coaching into its product offerings, Zepp Health aims to empower women with the tools and knowledge to optimize their health and wellness at every stage of life.
